Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)
Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –
Anbio Biotechnology cash
Cash and short-term investments held at the end of each period.
Anbio Biotechnology's cash was $11.90M at Dec 31, 2025. For fiscal 2025 it was $11.90M, up 1.2% from the year before. The highest annual figure on record is $11.90M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.90M | +1.2% |
| FY2024 | Dec 31, 2024 | $11.76M | +21.4% |
| FY2023 | Dec 31, 2023 | $9.69M | +36.4% |
| FY2022 | Dec 31, 2022 | $7.10M | +69.9% |
| FY2021 | Dec 31, 2021 | $4.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $11.90M | +184.6% |
| Q4 FY2024 | Dec 31, 2024 | $11.76M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.69M | – |
| Q4 FY2022 | Dec 31, 2022 | $7.10M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.18M | – |
See a number that looks wrong?